Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy

Journal of Viral Hepatitis

Volumn 7, Issue 3, 2000, Pages 203-210

  Pradat, Pierre ^a   Chossegros, P ^a   Bailly, F ^a   Pontisso, P ^b   Saracco, G ^c   Sauleda, S ^d   Thursz, M ^e   Tillmann, H ^f   Vlassopoulou, H ^g   Alberti, A ^b   Braconier, J H ^h   Esteban, J I ^d   Hadziyannis, S ^g   Manns, M ^f   Rizzetto, M ^c   Thomas, H C ^e   Trepo C ^a  

^a HÔTEL DIEU   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e ST MARY S HOSPITAL   (United Kingdom)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g HIPPOKRATION HOSPITAL   (Greece)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hepatitis C; Quantitative assay; Treatment

Indexed keywords

INTERFERON;

ARTICLE; HEPATITIS C; HUMAN; IMMUNOTHERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD;

ANTIVIRAL AGENTS; COHORT STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0034115727     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2000.00224.x     Document Type: Article

References (29)

1. 1 Di Bisceglie AM. Hepatitis C. Lancet 1998; 351: 351-355.
2. 2 Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-1466.
3. 3 Sakamoto N, Enomoto N, Kurosaki M, Marumo F, Sato C. Detection and quantification of hepatitis C virus RNA replication in the liver. J Hepatol 1994; 20: 593-597.
4. 4 De Moliner L, Pontisso P, De Salvo GL, Cavalletto L, Chemello L, Alberti A. Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features. Gut 1998; 42: 856-860.
5. 5 Tassopoulos NC, Papatheodoridis GV, Katsoulidou A et al. Factors associated with severity and disease progression in chronic hepatitis C. Hepatogastroenterology 1998; 45: 1678-1683.
6. 6 HENCORE. Hepatitis C European Network for Co-Operative Research. Guidelines for Control and Management of Hepatitis C. Report to the European Commission DG V, March 1998. Program of Community Action on the Prevention of AIDS and certain other Communicable Diseases, 1998.
7. 7 Kao JH, Lai MY, Chen PJ, Hwang LH, Chen DS. Serum hepatitis C virus titers in the progression of type C chronic liver disease. With special emphasis on patients with type 1b infection. J Clin Gastroenterol 1996; 23: 280-283.
8. 8 Hollingsworth RC, Sillekens P, van Deursen P, Neal KR, Irving WL. Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group. J Hepatol 1996; 25: 301-306.
9. 9 Fernandez I, Castellano G, Domingo MJ et al. Influence of viral genotype and level of viremia on the severity of liver injury and the response to interferon therapy in Spanish patients with chronic C infection. Scand J Gastroenterol 1997; 32: 70-76.
10. 10 Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol 1997; 35: 187-192.
11. 11 Tong MJ, Blatt LM, McHutchison JG, Co RL, Conrad A. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology 1997; 26: 1640-1645.
12. 12 Martinot-Peignoux M, Marcellin P, Pouteau M et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995; 22: 1050-1056.
13. 13 Shindo M, Arai K, Sokawa Y, Okuno T. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-α therapy. Ann Intern Med 1995; 122: 586-591.
14. 14 Booth JCL, Foster GR, Kumar U et al. Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon α. Gut 1995; 36: 427-432.
15. 15 Detmer J, Lagier R, Flynn J et al. Accurate quantification of Hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol 1996; 34: 901-907.
16. 16 Colucci G, Gutekunst K. Development of a quantitative PCR assay for monitoring HCV viraemia levels in patients with chronic hepatitis C. J Viral Hepat 1997; 4 (Suppl. 1): 75-78.
17. 17 Tong MJ, Hwang SJ, Lefkowitz M et al. Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin. J Gastroenterol Hepatol 1994; 9: 587-591.
18. 18 Stuyver L, Rossau R, Wyseur A et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-1102.
19. 19 Cuypers HT, Bresters D, Winkel IN et al. Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol 1992; 30: 3220-3224.
20. 20 Busch MP, Wilber JC, Johnson P, Tobler L, Evans CS. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992; 32: 420-425.
21. 21 Halfon P, Khiri H, Gerolami V et al. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J Hepatol 1996; 25: 307-311.
22. 22 Trabaud M-A, Bailly F, Colucci G, Trépo C. Stability of hepatitis C virus RNA in serum from samples collected in a closed-tube system for serum separation and transport, as measured by a quantitative competitive PCR assay. J Viral Hepat 1996; 3: 207-209.
23. 23 Trabaud MA, Bailly F, Si-Ahmed SN et al. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. J Med Virol 1997; 52: 105-112.
24. 24 Lunel F, Cresta P, Vitour D et al. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and Monitor assays. Hepatology 1999; 29: 528-535.
25. 25 Pawlotsky JM. Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology 1997; 26: 1-4.
26. 26 Tong CY, Hollingsworth RC, Williams H, Irving WL, Gilmore IT. Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor test and the Quantiplex HCV RNA 2.0 assay (bDNA). J Med Virol 1998; 55: 191-196.
27. 27 Berger A, Braner J, Doerr HW, Weber B. Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Intervirology 1998; 41: 24-34.
28. 28 Toyoda H, Kumada T, Nakano S et al. Significance of early measurement of serum hepatitis C virus RNA in predicting response to interferon therapy in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 1997; 9: 245-249.
29. 29 Marcellin P, Martinot M, Erlinger S. Early negative tests for serum HCV RNA as a predictor of sustained response to interferon therapy in patients with chronic hepatitis C. J Gastroenterol Hepatol 1997; 9: 237-238.